MIG Capital

MIG Capital is a Munich-based venture capital firm that invests in early-stage deep tech and life sciences companies across Europe. Since its inception in 2004, MIG has committed over €730 million to more than 50 startups, focusing on sectors such as biopharmaceuticals, energy and environmental technologies, advanced computing, digitalization/IoT, medical technology, and digital health. The firm's portfolio currently comprises 33 active companies.

MIG Capital's investment strategy centers on providing substantial capital to innovative startups in the seed and early stages, with typical investments ranging from €1 million to €50 million. The firm is known for its unique position as the only retail venture capital investor in Germany, with funds that are publicly accessible and fully funded by private individuals. This approach allows MIG to support founders with a long-term perspective, emphasizing sustainable growth and value creation.

The firm's team consists of engineers, scientists, physicians, and entrepreneurs who employ both analytical and creative processes to assess business models and technologies. Their extensive experience and network provide excellent access to companies, institutions, and decision-makers, facilitating the growth of their portfolio companies. MIG Capital has a track record of successful exits, including trade sales and IPOs, demonstrating its ability to realize value from its investments effectively.